Histone deacetylases: the critical enzymes for microglial activation involved in neuropathic pain
Neuropathic pain is a common health problem in clinical practice that can be caused by many different factors, including infection, ischemia, trauma, diabetes mellitus, nerve compression, autoimmune disorders, cancer, trigeminal neuralgia, and abuse of certain drugs. This type of pain can persistent...
Saved in:
| Main Author: | Yi Ding |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1515787/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulsed radiofrequency alleviates neuropathic pain by upregulating MG53 to inhibit microglial activation
by: Yuanxin Huang, et al.
Published: (2024-12-01) -
Inhibition of histone deacetylase 6 alleviates neuropathic pain via direct regulating post-translation of spinal STAT3 and decreasing downstream C-C Motif Chemokine Ligand 7 synthesis
by: Zhexi Chi, et al.
Published: (2025-03-01) -
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
by: Antonio Curcio, et al.
Published: (2024-05-01) -
Neuropathic pain: proposal of a mechanism-based treatment
by: Laura Demartini, et al.
Published: (2025-04-01) -
Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases
by: Maria A. Theodoropoulou, et al.
Published: (2024-12-01)